Immorta Bio Inc

04/29/2026

The planet is vast and rich-so much to see and do if you only have the time. And that's what Immorta Bio is pursuing-new methodologies conceived to kill old cells and preserve only the ones that make you younger.

04/26/2026

Immorta Bio is well aware that extra time is only valuable when it is lived, not merely survived. The goal is not immortality, but to remain fully oneself for as long as life allows. Learn more at www.immortabio.com.

04/16/2026

The road to life is long, but it goes by fast. So Immorta Bio's scientific mission is to radically extend healthy human lifespans by targeting the biological root causes of age-related diseases. Learn more at www.immortabio.com.

04/10/2026

Longevity is only meaningful when it's equitable. A longer life should come not with survival, but with freedom from frailty and chronic toxicity. Learn more at www.immortabio.com.

04/01/2026

Senovax™ is at the forefront of a new class of personalized immunotherapeutics designed to selectively eliminate capacity.
Learn more at www.immortabio.com.

03/26/2026

Immorta Bio is well aware that extra time is only valuable when it is lived, not merely survived. The goal is not immorality, but to remain fully oneself for as long as life allows. Learn more at www.immortabio.com.

03/18/2026

Immorta Bio is well aware that extra time is only valuable when it is lived, not merely survived. The goal is not immortality, but to remain fully oneself for as long as life allows. Learn more at www.immortabio.com.

03/12/2026

Big news from our lab, and it is the kind that makes you sit up straight.

Our latest preclinical research shows that combining two of our core platforms, SenoVax™ and StemCellRevivify™, produced approximately 73% increase in mean survival and ~84% extension of median lifespan in aging mouse models.

What does that mean in plain terms? We are targeting aging at its source.

SenoVax™ trains the immune system to clear out "zombie" cells that drive chronic inflammation and disease. StemCellRevivify™ restores the body's ability to repair and regenerate itself. Together, they work in ways neither could alone.

This research has been accepted for presentation at one of the world's leading immunology conferences, , happening this April in Boston.
We are moving fast. Human clinical trials are on the horizon, with an early focus on liver disease and cancer.

Read the full announcement: https://www.prnewswire.com/news-releases/immorta-bio-demonstrates-dramatic-lifespan-extension-in-aging-mouse-models-research-accepted-for-presentation-at-aais-immunology2026-302711019.html?tc=eml_cleartime

/PRNewswire/ -- Immorta Bio Inc., a scientific longevity biotechnology company dedicated to Treating Diseases of Aging and Treating Aging as Disease™, today...

03/10/2026

SenoVax empowers the body to recognize and remove harmful senescent cells, paving the way for healthier aging, extended vitality, and prevention of age-related diseases, including cancer. Learn more at www.immortabio.com.